Anna is the staff Cancer Research Marketing Manager at Illumina. Her aim is to enable researchers to use established and emerging NGS applications to bring cancer research to the next level. Currently she is focusing on enabling Multiomic studies by providing internal and external education.
Before joining Illumina, Anna worked as R&D scientist at QIAGEN. She has a PhD from University of Hamburg, Germany and worked as a PostDoc at the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf. She focused on translational cancer research and liquid biopsy. Anna was involved in the IMI consortium Cancer-ID and has authored >10 peer-reviewed journal articles and a chapter in World Cancer Report 2020.
Tuesday, 17 June 2025
| Time |
Session |
|
|
13:30
14:15
|
-
Introduction to multiomics
-
Rapid WGS with Constellation read map technology for paediatric cancer research
-
Identification of biomarkers for early detection of colorectal cancer: multiomic, epigenetic and metagenomic analysis of rectal mucus sampling
-
BreakThrough Spotlight – Early Career Researcher Unravelling Tumour Genetics: The Role of cfDNA Whole-Exome Sequencing in Treatment Response Assessment
-
Q&A and panel discussion
Auditorium II
|
